Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 5:52 AM UTC
| NCT Number | NCT06800313 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE1 |
| Target Enrollment | 190 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Halda Therapeutics OpCo, Inc. |
| Last Updated on CT.gov | September 25, 2026 (2 weeks ago) |
As of October 15, 2026: Clinical trial NCT06800313 is currently recruiting participants. This phase1 study for prostate cancer is actively seeking new participants at 17 locations across the United States. The study is sponsored by Halda Therapeutics OpCo, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06800313 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06800313 was last updated 2 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.